Opportunity Information: Apply for RFA DA 11 002
Apply for RFA DA 11 002
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Sep 23, 2010 and posted on Sep 23, 2010.
- Applicants must submit their applications by May 26, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Special district governments City or township governments Small businesses County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) is a National Institutes of Health funding opportunity designed to support unusually creative, high-impact HIV/AIDS research specifically tied to drug abuse and addiction. Its main goal is to complement NIDA's standard investigator-initiated grants by backing individual scientists who are proposing bold, potentially transformative ideas that could open entirely new directions for preventing or treating HIV/AIDS among people who use drugs. In this context, "avant garde" signals that NIDA is looking for work that is genuinely unconventional and substantially different from what the applicant (or the broader field) is already doing, rather than incremental extensions of existing projects.
A key requirement is that the proposed research must align with areas described in the Trans-NIH Plan for HIV-Related Research (FY 2011). In other words, even though the award is meant to fund high-risk, high-reward ideas, it still needs to fit within the broader federal HIV research priorities laid out across NIH. The program explicitly aims for research that could be transformative, meaning it might create new scientific avenues, reshape current approaches, or lead to new prevention and treatment strategies for HIV/AIDS in drug-abusing populations.
The competition is structured in two phases. First, investigators submit a pre-application under a separate solicitation (PAR-10-287). Those pre-applications are reviewed by external reviewers, and only the most outstanding submissions are invited to move forward. The current announcement (RFA-DA-11-002) covers the second phase, where invited applicants submit full applications using the NIH DP1 mechanism, which is typically associated with high-impact, pioneering research. Final awardees for 2011 are chosen from among those invited full applications, so applicants cannot simply submit a full application without first being selected in the pre-application stage.
NIDA anticipated committing about $2 million total in fiscal year 2011 to support approximately 2 to 3 awards, assuming enough applications of strong scientific merit were received. The funding instrument type is a grant, and the opportunity falls under education and health-related federal assistance (CFDA 93.279, Drug Abuse and Addiction Research Programs). There is no cost sharing or matching requirement.
Eligibility is broad and includes many types of domestic organizations and institutions. Eligible applicants listed include state, county, city or township, special district, and certain tribal governments; public and private institutions of higher education; nonprofit organizations with or without 501(c)(3) status; small businesses; other for-profit organizations; independent school districts; public housing authorities/Indian housing authorities; and additional categories such as historically Black colleges and universities, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. The overall intent is to allow a wide range of capable entities to support exceptional investigators pursuing novel HIV/AIDS research connected to drug abuse.
Administratively, the opportunity was posted on September 23, 2010, with a closing date of May 26, 2011 (and an archive date of June 26, 2011). The sponsoring agency is NIH, with NIDA as the institute leading this specific program. The full announcement and details were made available through NIH's grants guide, and NIH provided webmaster contacts for technical issues accessing or linking to the announcement.
Frequently Asked Questions (FAQs)
What is the 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1)?
The 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) is a National Institutes of Health (NIH) funding opportunity led by the National Institute on Drug Abuse (NIDA). It is designed to support unusually creative, high-impact HIV/AIDS research that is specifically tied to drug abuse and addiction, with an emphasis on bold ideas that could reshape prevention or treatment strategies for HIV/AIDS among people who use drugs.
What is the main purpose of this award program?
The program is intended to complement NIDA's standard investigator-initiated grants by supporting individual scientists proposing pioneering, potentially transformative concepts. The goal is to help launch entirely new directions in HIV/AIDS research as it relates to drug abuse and addiction, rather than funding incremental extensions of existing projects.
What does "avant garde" mean in this funding opportunity?
In this context, "avant garde" signals that NIDA is looking for research that is genuinely unconventional and substantially different from what the applicant or the broader scientific field is already doing. The focus is on high-risk, high-reward ideas with the potential to be transformative.
What research topics or scope does the program target?
The proposed work must be HIV/AIDS research that is tied to drug abuse and addiction. The program explicitly aims to support ideas that could open new scientific avenues or lead to new approaches for preventing or treating HIV/AIDS in drug-abusing populations.
Does the proposed research have to align with any federal research plan or priorities?
Yes. A key requirement is that the proposed research must align with areas described in the Trans-NIH Plan for HIV-Related Research (FY 2011). Even though the award emphasizes bold and unconventional ideas, it still needs to fit within broader NIH HIV research priorities.
Is this a standard NIH grant or a special mechanism?
The second phase uses the NIH DP1 mechanism, which is typically associated with high-impact, pioneering research. The funding instrument type is a grant.
Is there a required pre-application step before submitting a full application?
Yes. The competition is structured in two phases. Investigators must first submit a pre-application under a separate solicitation (PAR-10-287). Those pre-applications are reviewed by external reviewers, and only the most outstanding submissions are invited to submit full applications under the second-phase announcement.
Can an applicant submit a full application without being invited?
No. Full applications under the second-phase announcement (RFA-DA-11-002) are only submitted by applicants who were invited after the pre-application review. Applicants cannot simply submit a full application without first being selected in the pre-application stage.
What solicitation covers the pre-application phase?
The pre-application phase is submitted under the separate solicitation PAR-10-287.
What announcement covers the invited full application phase?
The second phase, for invited full applications, is covered by RFA-DA-11-002.
Who reviews the pre-applications?
Pre-applications are reviewed by external reviewers, and only the most outstanding submissions move forward to the invited full-application stage.
How many awards did NIDA expect to make in fiscal year 2011?
NIDA anticipated making approximately 2 to 3 awards in fiscal year 2011, assuming a sufficient number of applications of strong scientific merit were received.
How much total funding was anticipated for fiscal year 2011?
NIDA anticipated committing about $2 million total in fiscal year 2011 for this program.
Is there any cost sharing or matching requirement?
No. The opportunity states that there is no cost sharing or matching requirement.
What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.279, Drug Abuse and Addiction Research Programs.
Which agency sponsors this funding opportunity?
The sponsoring agency is the National Institutes of Health (NIH), with the National Institute on Drug Abuse (NIDA) leading this specific program.
What types of organizations are eligible to apply?
Eligibility is broad and includes many types of domestic organizations and institutions. Eligible applicants include state, county, city or township governments; special district governments; certain tribal governments; public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); small businesses; other for-profit organizations; independent school districts; public housing authorities/Indian housing authorities; and additional categories such as historically Black colleges and universities, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
Is the program limited to universities, or can other entities apply?
It is not limited to universities. While public and private institutions of higher education are eligible, the program also lists a wide range of other eligible entities, including government organizations, nonprofits (with or without 501(c)(3) status), small businesses, for-profit organizations, and other eligible institutions and organizations.
When was this opportunity posted, and what were the key dates?
The opportunity was posted on September 23, 2010. The closing date was May 26, 2011, and the archive date was June 26, 2011.
Where were the full announcement and details made available?
The full announcement and details were made available through the NIH grants guide.
Who should be contacted for technical issues accessing or linking to the announcement?
NIH provided webmaster contacts for technical issues related to accessing or linking to the announcement.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Pre Application for the 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (X02)
Previous opportunity: National Coal Heritage Area implement management plan
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 11 002
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 11 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pre Application for the 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 10 287 Funding Number: PAR 10 287 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Resource Related Research Projects for Development of Animal Models and Related Materials (R24) Apply for PAR 10 289 Funding Number: PAR 10 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 10 290 Funding Number: PA 10 290 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 10 291 Funding Number: PA 10 291 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Tumor Microenvironment Network (TMEN) (U54) Apply for RFA CA 10 021 Funding Number: RFA CA 10 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $700,000 |
| Animal and Biological Material Resource Centers (P40) Apply for PAR 11 001 Funding Number: PAR 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 11 005 Funding Number: PAR 11 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) Apply for RFA CA 11 001 Funding Number: RFA CA 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) Apply for PA 11 009 Funding Number: PA 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008 Funding Number: PA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PA 11 006 Funding Number: PA 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PA 11 007 Funding Number: PA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| HIV Infection of the Central Nervous System (R01) Apply for PA 11 014 Funding Number: PA 11 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Gene Vector Biorepository and Coordinating Center (P40) Apply for RFA RR 10 010 Funding Number: RFA RR 10 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medical Marijuana Policy Research Exploring Trends and Impacts (R01) Apply for RFA DA 11 008 Funding Number: RFA DA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Molecular Genetics of Drug Addiction and Related Co Morbidities (R01) Apply for PA 11 026 Funding Number: PA 11 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Support Opportunity for Addiction Research (SOAR) for New Investigators (R03) Apply for RFA DA 11 010 Funding Number: RFA DA 11 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse (R01) Apply for PA 11 027 Funding Number: PA 11 027 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Continued Development and Maintenance of Software (R01) Apply for PAR 11 028 Funding Number: PAR 11 028 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Statistical Coordination Center for the Population based Research Optimizing Screening through Personalized Regimens (PROSPR)(U01) Apply for RFA CA 11 004 Funding Number: RFA CA 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 11 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.